NEW YORK, March 19, 2018 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Myriad Genetics, Inc. (“Myriad Genetics” or the “Company”) (NASDAQ: MYGN).
After market close on March 12, 2018, Myriad Genetics filed…
